NCT/Study#
NCT05256745 /
RAGE-IIT
RAGE inhibition to decrease cancer therapy related cardio toxicity in women with early breast cancer
DISEASE GROUP:
Breast Cancer Clinical Trials
current phase:
Phase II/III
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
